Efficacy of fourth-line targeted therapy in patients with metastatic renal cell carcinoma: a retrospective analysis.
Bernhard RallaBarbara ErberIrena GoranovaLuise von der AueAnne FloerckenStefan HinzCarsten KempkensteffenAhmed MagheliKurt MillerJonas BuschPublished in: World journal of urology (2015)
Patients might benefit from subsequent treatment lines independently from treatment response in first line.